« Back to Record
Cortes, J., Buchanan, J., Tagliaferri, M., Hannah, A. L., O'Shaughnessy, J., Rugo, H., Twelves, C., Awada, A., Perez, E. A., Im, S. A., Zhao, C., Hoch, U., & Tomkinson, D. (2016). Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial. SpringerPlus, 5(1), 1033. doi:10.1186/s40064-016-2446-4
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/236986



